HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Chitnis Selected Research

HLA-C Antigens (HLA-C)

8/2010HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Chitnis Research Topics

Disease

7Multiple Sclerosis
02/2018 - 05/2009
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2001 - 03/2001
1Lymphopenia (Lymphocytopenia)
02/2018
1Infections
06/2011
1Immune System Diseases (Immune Disorders)
05/2009
1Autoimmune Diseases (Autoimmune Disease)
03/2001
1Demyelinating Diseases (Demyelinating Disease)
04/2000

Drug/Important Bio-Agent (IBA)

2HLA-DRB1 Chains (HLA DRB1)IBA
06/2011 - 08/2010
1Fingolimod Hydrochloride (FTY720)FDA Link
02/2018
1Natalizumab (Tysabri)FDA Link
02/2018
1Dimethyl FumarateIBA
02/2018
1Particulate MatterIBA
12/2017
1Testosterone (Sustanon)FDA Link
10/2014
1SteroidsIBA
10/2014
1HLA-C Antigens (HLA-C)IBA
08/2010
1HLA-B Antigens (HLA-B)IBA
08/2010
1HLA-A Antigens (HLA-A)IBA
08/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2009
1Hormones (Hormone)IBA
05/2009
1Gonadal Steroid Hormones (Sex Hormones)IBA
05/2009
1CytokinesIBA
09/2001
1AntigensIBA
03/2001
1Immunoglobulins (Immunoglobulin)IBA
04/2000

Therapy/Procedure

3Therapeutics
01/2012 - 03/2001
1Duration of Therapy
02/2018